apl. Prof. Dr. Oliver Ott

Medizinische Fakultät

Low- vs. high-dose radiotherapy in Graves’ ophthalmopathy: a retrospective comparison of long-term results (2021) Weissmann T, Lettmaier S, Donaubauer AJ, Bert C, Schmidt M, Kruse F, Ott O, et al. Journal article Tumour-infiltrating inflammatory cells in early breast cancer: An underrated prognostic and predictive factor? (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Journal article Analysis of antioxidant Factors in Patients' Blood with chronic Degenerative and inflammatory Diseases in the Course of Low-Dose Radiotherapy (2020) Hehlgans S, Donaubauer AJ, Becker I, Frey B, Oppermann J, Ott O, Weissmann T, et al. Conference contribution Accelerated Partial Breast Irradiation: Identification of High Risk Tumors in Early Hormone Receptor-positive Breast Cancer by Macrophage Shift Classification (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Conference contribution Defnitive Radiochemotherapy with and without regional Deep Hyperthermia of Bladder Carcinoma in elderly Patients (2020) Siavooshhaghighi H, Putz F, Gryc T, Mansoorian S, Filimonova I, Fietkau R, Ott O Conference contribution Accelerated Partial Breast Irradiation: Frequent non-professional Phagocytosis in Patients with early, Hormone Receptor-positive Breast Cancer is associated with good Survival (2020) Bauer M, Schnellhardt S, Rosahl MC, Erber R, Ott O, Fietkau R, Distel L Conference contribution Analysis of the analgesic Effects of LDRT in Patients in the IMMO-LDRT01 Study (2020) Fröhlich B, Donaubauer AJ, Weissmann T, Becker I, Ott O, Fietkau R, Gaipl U, Frey B Conference contribution Low-dose Radiotherapy for painful Finger Joint Arthrosis (2020) Weissmann T, Ott O, Putz F, Becker I, Fietkau R, Donaubauer AJ, Frey B Conference contribution Is it time to redefine the role of low-dose radiotherapy for benign disease? (2020) Montero A, Sabater S, Roedel F, Gaipl U, Ott O, Seegenschmiedt MH, Arenas M Journal article, Letter Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: First (treatment planning) results of the prospective multicenter DIREKHT trial (2020) Haderlein M, Speer S, Ott O, Lettmaier S, Hecht M, Semrau S, Frey B, et al. Journal article